Cite
MLA Citation
Elizabeth Hyland et al.. “Comparison of the pharmacokinetics, safety, and immunogenicity of MSB11022, a biosimilar of adalimumab, with Humira® in healthy subjects.” British journal of clinical pharmacology, vol. 82, n.d., pp. 983–993. http://access.bl.uk/ark:/81055/vdc_100035886670.0x000024